Search results
15 sie 2011 · Treatment for seven to 14 days is recommended, but should be individualized to the patient's clinical response.
- AAFP News Now
The prevalence of methicillin-resistant Staphylococcus...
- AAFP News Now
29 lis 2023 · According to the European Committee on Antimicrobial Susceptibility Testing (EUCAST), S. aureus with oxacillin MIC values >2 mg/L are mostly methicillin resistant [2]. Issues related to treatment of skin and soft tissue infections in adults caused by MRSA will be reviewed here.
1 lut 2011 · For health care–associated MRSA (HA-MRSA) or CA-MRSA pneumonia, IV vancomycin (A-II) or linezolid 600 mg PO/IV twice daily (A-II) or clindamycin 600 mg PO/IV 3 times daily (B-III), if the strain is susceptible, is recommended for 7–21 days, depending on the extent of infection.
13 mar 2014 · This regimen was associated with a reduction in the mean rate of MRSA infection, from 0.84 to 0.03 infections per month; these results suggest that a longer treatment duration and treatment...
3 lut 2021 · Consider clindamycin, co-trimoxazole, or doxycycline as oral agents (when the isolate is susceptible) for treatment of patients with mild skin and soft tissue infection caused by MRSA, or for oral stepdown therapy (weak recommendation).
1 lut 2011 · The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections.
26 sie 2024 · MRSA TREATMENT. If MRSA infection is diagnosed, you will be given an antibiotic. There are now a large number of antibiotics that can be successfully used to treat MRSA infections. The antibiotic dose or type may be changed when the results of the laboratory culture are available.
